TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
20 hedge funds and large institutions have $759K invested in Titan Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
20
Holding in Top 10
–
Calls
$21K
Puts
–
Top Buyers
| 1 | +$1K | |
| 2 | +$268 | |
| 3 | +$237 | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$156 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$110 |
Top Sellers
| 1 | -$41K | |
| 2 | -$30K | |
| 3 | -$19K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.88K |